MDM2 mutations found in several cancers, which disrupt the RPL11-MDM2 interaction, attenuate the p53-mediated response to nucleolar/ribotoxic stress and accelerate c-Myc-induced lymphomagenesis in a mouse model system (Macias et al., 2010; Pan et al., 2011). The gene discussed is MDM2; the disease is cancer.